Caring for Individuals With Intellectual and Developmental Disabilities in the COVID-19 Crisis

Overview

Journal Neurol Clin Pract

Date 2021 Apr 12

PMID 33842088

Citations 3

Authors

Jessica Solomon Sanders

Seth Keller

Bhooma R Aravamuthan

Affiliations

Soon will be listed here.

Abstract

Individuals with intellectual and developmental disabilities (IDDs) are among our most medically vulnerable neurologic patient population. As such, they are at particular risk of psychosocial and medical harm during the coronavirus disease 2019 (COVID-19) pandemic. Here, we highlight strategies to decrease potential infectious exposures and ensure continued optimal neurologic care for individuals with IDD during the COVID-19 pandemic. Finally, in a climate of potential medical resource restriction, we offer some suggestions for advocacy on behalf of individuals with IDD.

Citing Articles

Erratum: Caring for Individuals With Intellectual and Developmental Disabilities in the COVID-19 Crisis.

Neurol Clin Pract. 2022; 11(6):981.

PMID: 34987883 PMC: 8723974. DOI: 10.1212/CPJ.0000000000000967.

Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity.

Sherby M, Kalb L, Coller R, DeMuri G, Butteris S, Foxe J Pediatrics. 2021; 149(12 Suppl 2).

PMID: 34737172 PMC: 8926067. DOI: 10.1542/peds.2021-054268H.

A Framework-Based Approach to Assessing Mental Health Impacts of the COVID-19 Pandemic on Children and Adolescents.

Lin P, Srivastava G, Beckman L, Kim Y, Hallerback M, Barzman D Front Psychiatry. 2021; 12:655481.

PMID: 34054613 PMC: 8155579. DOI: 10.3389/fpsyt.2021.655481.

References

Koo J, Cook A, Park M, Sun Y, Sun H, Lim J . Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020; 20(6):678-688. PMC: 7158571. DOI: 10.1016/S1473-3099(20)30162-6. View

Tilton A . Transition of Children with Neurological Disorders. Curr Neurol Neurosci Rep. 2018; 18(4):14. DOI: 10.1007/s11910-018-0822-x. View

Lewis J, Gregorian T, Portillo I, Goad J . Drug interactions with antimalarial medications in older travelers: a clinical guide. J Travel Med. 2019; 27(1). DOI: 10.1093/jtm/taz089. View

Maulik P, Mascarenhas M, Mathers C, Dua T, Saxena S . Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 2011; 32(2):419-36. DOI: 10.1016/j.ridd.2010.12.018. View

Fauci A, Lane H, Redfield R . Covid-19 - Navigating the Uncharted. N Engl J Med. 2020; 382(13):1268-1269. PMC: 7121221. DOI: 10.1056/NEJMe2002387. View

Vawter D, Garrett J, Gervais K, Witt Prehn A, DeBruin D . Attending to social vulnerability when rationing pandemic resources. J Clin Ethics. 2011; 22(1):42-53. View

Arons M, Hatfield K, Reddy S, Kimball A, James A, Jacobs J . Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020; 382(22):2081-2090. PMC: 7200056. DOI: 10.1056/NEJMoa2008457. View

. Patient- and family-centered care coordination: a framework for integrating care for children and youth across multiple systems. Pediatrics. 2014; 133(5):e1451-60. DOI: 10.1542/peds.2014-0318. View

Klein B, Busis N . COVID-19 is catalyzing the adoption of teleneurology. Neurology. 2020; 94(21):903-904. DOI: 10.1212/WNL.0000000000009494. View

10.

Hughes K, Bellis M, Jones L, Wood S, Bates G, Eckley L . Prevalence and risk of violence against adults with disabilities: a systematic review and meta-analysis of observational studies. Lancet. 2012; 379(9826):1621-9. DOI: 10.1016/S0140-6736(11)61851-5. View

11.

Chapman J, Cadilhac D, Gardner B, Ponsford J, Bhalla R, Stolwyk R . Comparing face-to-face and videoconference completion of the Montreal Cognitive Assessment (MoCA) in community-based survivors of stroke. J Telemed Telecare. 2019; 27(8):484-492. DOI: 10.1177/1357633X19890788. View

12.

OSullivan T, Phillips K . From SARS to pandemic influenza: the framing of high-risk populations. Nat Hazards (Dordr). 2020; 98(1):103-117. PMC: 7088565. DOI: 10.1007/s11069-019-03584-6. View

13.

Mehra M, Desai S, Kuy S, Henry T, Patel A . Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020; 382(25):e102. PMC: 7206931. DOI: 10.1056/NEJMoa2007621. View

14.

Hatcher-Martin J, Adams J, Anderson E, Bove R, Burrus T, Chehrenama M . Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update. Neurology. 2019; 94(1):30-38. DOI: 10.1212/WNL.0000000000008708. View

15.

Altena E, Baglioni C, Espie C, Ellis J, Gavriloff D, Holzinger B . Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J Sleep Res. 2020; 29(4):e13052. DOI: 10.1111/jsr.13052. View

16.

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

17.

Hollander J, Carr B . Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020; 382(18):1679-1681. DOI: 10.1056/NEJMp2003539. View

18.

Ervin D, Hennen B, Merrick J, Morad M . Healthcare for persons with intellectual and developmental disability in the community. Front Public Health. 2014; 2:83. PMC: 4098023. DOI: 10.3389/fpubh.2014.00083. View